Rajan Sharma

Stock Analyst at Goldman Sachs

(0.36)

# 4,063

Out of 4,834 analysts

4

Total ratings

33.33%

Success rate

-15.53%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Rajan Sharma

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AZN AstraZeneca	Initiates: Buy	$97	$67.96	+42.73%	1	May 30, 2024
	GSK GSK plc	Initiates: Neutral	$47	$37.57	+25.10%	1	May 30, 2024
	IMCR Immunocore Holdings	Reiterates: Overweight	$79	$29.06	+171.85%	2	Jun 20, 2023

AstraZeneca

May 30, 2024

Initiates: Buy

Price Target: $97

Current: $67.96

Upside: +42.73%

GSK plc

May 30, 2024

Initiates: Neutral

Price Target: $47

Current: $37.57

Upside: +25.10%

Immunocore Holdings

Jun 20, 2023

Reiterates: Overweight

Price Target: $79

Current: $29.06

Upside: +171.85%